Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Director Reeve B. Waud sold 100,000 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $31.80, for a total value of $3,180,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Shares of Acadia Healthcare Company, Inc. (NASDAQ ACHC) opened at $32.52 on Wednesday. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 1.30. The stock has a market capitalization of $2,788.47, a price-to-earnings ratio of 13.86, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. Acadia Healthcare Company, Inc. has a one year low of $26.92 and a one year high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.07). The company had revenue of $716.70 million during the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The business’s quarterly revenue was down 2.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.58 earnings per share. equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 2.23 EPS for the current fiscal year.

Several equities analysts have recently commented on the company. BMO Capital Markets assumed coverage on Acadia Healthcare in a research note on Monday, October 16th. They set an “outperform” rating and a $52.00 target price for the company. Jefferies Group set a $42.00 target price on Acadia Healthcare and gave the company a “buy” rating in a research note on Wednesday, October 25th. Craig Hallum reiterated a “buy” rating and set a $41.00 target price (down from $65.00) on shares of Acadia Healthcare in a research note on Thursday, October 26th. Zacks Investment Research cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, October 2nd. Finally, Bank of America reduced their target price on Acadia Healthcare from $60.00 to $52.00 and set a “buy” rating for the company in a research note on Wednesday, October 25th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $45.08.

A number of hedge funds have recently bought and sold shares of the business. Arthur Zaske & Associates LLC bought a new stake in Acadia Healthcare in the third quarter valued at $283,000. Neuberger Berman Group LLC lifted its stake in Acadia Healthcare by 5.1% in the third quarter. Neuberger Berman Group LLC now owns 879,951 shares of the company’s stock valued at $42,026,000 after buying an additional 42,713 shares during the last quarter. Granahan Investment Management Inc. MA lifted its stake in Acadia Healthcare by 11.6% in the third quarter. Granahan Investment Management Inc. MA now owns 69,011 shares of the company’s stock valued at $3,296,000 after buying an additional 7,186 shares during the last quarter. Jane Street Group LLC bought a new stake in Acadia Healthcare in the third quarter valued at $316,000. Finally, Envestnet Asset Management Inc. lifted its stake in Acadia Healthcare by 266.9% in the third quarter. Envestnet Asset Management Inc. now owns 80,684 shares of the company’s stock valued at $3,855,000 after buying an additional 58,692 shares during the last quarter.

WARNING: “Reeve B. Waud Sells 100,000 Shares of Acadia Healthcare Company, Inc. (ACHC) Stock” was published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://www.watchlistnews.com/reeve-b-waud-sells-100000-shares-of-acadia-healthcare-company-inc-achc-stock/1773871.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Insider Buying and Selling by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.